Abstract
Amplification of the CCDN1 gene encoding cyclin D1 was examined by Southern blotting and multiplex polymerase chain reaction (PCR) and occurred in 8 of 53 patients (15%) with primary resected non-small-cell lung cancer (NSCLC). These tumours and 17 additional tumours with a normal gene copy number showed overexpression of cyclin D1 (25/53, 47%), as assessed by immunostaining using a monoclonal antibody. In 22/25 cases, cyclin D1 was localised in the cytoplasm, but some (7/25) had simultaneous nuclear staining. This result is in marked contrast to that reported in breast, hepatocellular and colorectal carcinoma studies where immunostaining was invariably nuclear. Examination of a restriction fragment length polymorphic (RFLP) site within the 3'untranslated region of the cDNA following reverse transcriptase (RT)-PCR (29/53 informative cases) showed a strong association between cytoplasmic staining and imbalance in allele-specific message levels. Cyclin D1 overexpression was associated with a poorly differentiated histology (P = 0.04), less lymphocytic infiltration of the tumour (P = 0.02) and a reduction in local relapse rate (P = 0.01). The relative risk of local relapse was 9.1 in tumours without cyclin D1 overexpression (P = 0.01, Cox regression analysis). We conclude that genetic alteration of cyclin D1 is a key abnormality in lung carcinogenesis and may have diagnostic and prognostic importance in the treatment of resectable NSCLC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Betticher, D., Heighway, J., Hasleton, P. et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 73, 294–300 (1996). https://doi.org/10.1038/bjc.1996.52
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.52
This article is cited by
-
Clinical significance of the histological and molecular characteristics of ependymal tumors: a single institution case series from China
BMC Cancer (2019)
-
Downregulation of TCEAL7 expression induces CCND1 expression in non-small cell lung cancer
Molecular Biology Reports (2019)
-
HOXA4, down-regulated in lung cancer, inhibits the growth, motility and invasion of lung cancer cells
Cell Death & Disease (2018)
-
Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma
Medical Oncology (2013)
-
Overexpression of cyclin Y in non-small cell lung cancer is associated with cancer cell proliferation
Science China Life Sciences (2010)